Three proven technology platforms — stabilization, magnetic-bead extraction, and methylation detection — combine with manufacturing discipline to deliver reagents you can trust, batch after batch.
From the moment of collection to a decision-ready result, our platforms are engineered to protect analytes, maximize recovery, and keep every step reproducible.
Proprietary stabilizers inhibit nuclease activity and protect blood samples at ambient temperature, preserving cfDNA and cfRNA integrity from the point of draw through transport and storage.
High-yield magnetic-bead chemistry optimized for low-abundance nucleic acids across plasma, whole blood, urine, stool, swabs, and tissue — built for automated high-throughput workflows.
An integrated solution spanning bisulfite conversion, multiplex targeted methylation qPCR, and clear result interpretation — enabling sample-to-result workflows designed for early cancer screening.
Built to accept the sample types your lab already handles and to slot cleanly into your existing extraction or conversion instruments — using Aequivera reagents end-to-end or extending third-party platforms of your choice.
Magnetic-bead chemistry paired with Aequivera extraction and conversion kits completes the sample-to-product workflow in roughly 1.5 hours — fully automated, no hands-on steps between start and finish.
Whole-blood collection through stabilized preservation to an analyzer-ready convert-and-purify product.
Convenient stool sampling with built-in preservation buffer, run through a single automated extraction-plus-conversion path.
Request documentation, validation data, or evaluation samples for your laboratory.
Contact us →